Effect of Aerobic Interval Training With Vitamin D Supplement on Functional Capacity and Perceived Myalgia

May 29, 2020 updated by: Heba Ahmed Ali Abdeen, Cairo University

Effect of Aerobic Interval Training Combined With Vitamin D Supplement on Functional Capacity and Perceived Myalgia in Middle Aged Obese Women

This study aimed to investigate whether there will be an effect of adding a program of aerobic interval training in managing patients suffering from myalgia associated with vitamin D deficiency.

Study Overview

Detailed Description

Forty five women complaining from myalgia with vitamin D deficiency participating in this study. Their ages are ranged from 30 to 40 years.

They are assigned randomly into three groups:

  • Group (A): included 15 patients who are participating in an aerobic interval training exercise program with vitamin D supplementation (cholecalciferol 400 IU/day).
  • Group (B): included 15 patients who are receiving vitamin D supplementation only (cholecalciferol 400 IU/day).
  • Group (C): included 15 patients who are participating in an interval training exercise program only.

The intervention will last for 12 weeks

Study Type

Interventional

Enrollment (Actual)

45

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 12316
        • Faculty of Physical Therapy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Forty five sedentry women with non specific myalgia pain.
  • The patients' ages ranged from 30 -40 years.
  • All patients have non specific muscle pain for more than 2 months.
  • They have vitamin D deficiency.
  • All patients have BMI from 25 to 34.9 kg/m2.
  • All patients were clinically and medically stable when attending the study.

Exclusion Criteria:

  • Unstable cardiovascular and chest problems.
  • Patients with diseases which affect vitamin D level as a history of rheumatic or metabolic bone diseases and diabetes.
  • Patients taking drugs which affect vitamin D level as steroids and anticonvulsants drugs .
  • Musculoskeletal disorders which may affect their physical ability to do the exercises.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group (A)

Included 15 patients who are participating in an aerobic interval training exercise program with vitamin D supplementation (cholecalciferol 400 IU/day).

The aerobic interval training is conducted for one hour, three days per week on a total period of 12 weeks.

The participants in both groups A will be instructed to perform aerobic interval exercises at 70% maxHR for 5 minutes and then decrease activity to 50% for 5 minutes and repeat for the length of the activity (the training will be done by using bicycle ergometer(Biodex LBC, Biodex Inc., New York).• Before starting training ; Maximum heart rate calculated from the following equation: maxHR= 220-age .

  • Duration: the first five to ten minutes of each session were dedicated to warming up exercise on the bicycle in the form of slow progression exercise (to decrease the risk of hypotension, musculoskeletal injury and cardiovascular complications), followed by the active phase of exercise for 40 min., and finally cooling down phase for ten minutes. with intensity and speed decreased gradually until reaching the resting HR
  • Frequency: 3 days/week., for 12 weeks

Also all participants in this group are taking gne capsule containing (cholecalciferol 400 IU) every day .

Experimental: Group (B)
Included 15 patients who are receiving vitamin D supplementation only . One capsule containing (cholecalciferol 400 IU) was taken every day for 12 weeks
One capsule containing (cholecalciferol 400 IU) was taken every day .
Experimental: Group (c)
Included 15 patients who are participating in an aerobic interval training exercise program only. The aerobic interval training is conducted for one hour, three days per week on a total period of 12 weeks.

The participants in group C will be instructed to perform aerobic interval exercises at 70% maxHR for 5 minutes and then decrease activity to 50% for 5 minutes and repeat for the length of the activity (the training will be done by using bicycle ergometer(Biodex LBC, Biodex Inc., New York).• Before starting training ; Maximum heart rate calculated from the following equation: maxHR= 220-age (Gellish ,2007).

  • Duration: the first five to ten minutes of each session were dedicated to warming up exercise on the bicycle in the form of slow progression exercise (to decrease the risk of hypotension, musculoskeletal injury and cardiovascular complications), followed by the active phase of exercise for 40 min., and finally cooling down phase for ten minutes. with intensity and speed decreased gradually until reaching the resting heart rate (Broderick et al.,2014).
  • Frequency: 3 days/week. The whole training lasting for 12 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Concentration of Plasma Serum vitamin D level (25OHD)
Time Frame: It is performed before and after the study(12 weeks interval) for all groups
It is performed by Laboratory BioPlex® 2200 System
It is performed before and after the study(12 weeks interval) for all groups
Description of Functional capacity efficiency
Time Frame: It is performed before and after the study(12 weeks interval) for all groups
Cooper 12-Minute Walk Test (12MWT)
It is performed before and after the study(12 weeks interval) for all groups
Intensity of non specific muscle pain (myalgia)
Time Frame: It is performed before and after the study(12 weeks interval) for all groups
A 10-cm Visual Analogue Scale (VAS) was used to evaluate the patients' pain , with 0 representing no pain and 10 representing the worst pain imaginable
It is performed before and after the study(12 weeks interval) for all groups
Description of the improvement in Quality of life
Time Frame: It is performed before and after the study(12 weeks interval) for all groups
The Short form health survey (SF-12)is often used to compare health status between groups of patients, to indentify predictors of health status
It is performed before and after the study(12 weeks interval) for all groups

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 12, 2020

Primary Completion (Actual)

May 15, 2020

Study Completion (Actual)

May 20, 2020

Study Registration Dates

First Submitted

March 22, 2020

First Submitted That Met QC Criteria

March 22, 2020

First Posted (Actual)

March 24, 2020

Study Record Updates

Last Update Posted (Actual)

June 2, 2020

Last Update Submitted That Met QC Criteria

May 29, 2020

Last Verified

May 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vitamin D Deficiency

Clinical Trials on aerobic interval training and Vitamin D supplementation,

Subscribe